Wellington Management Group LLP cut its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 91.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 82,392 shares of the company’s stock after selling 839,766 shares during the quarter. Wellington Management Group LLP’s holdings in Avantor were worth $1,336,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wealthquest Corp purchased a new stake in Avantor during the 1st quarter worth approximately $34,000. GAMMA Investing LLC increased its holdings in shares of Avantor by 121.6% in the 1st quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock valued at $61,000 after acquiring an additional 2,056 shares during the last quarter. Fifth Third Bancorp increased its holdings in shares of Avantor by 52.0% in the 1st quarter. Fifth Third Bancorp now owns 3,972 shares of the company’s stock valued at $64,000 after acquiring an additional 1,359 shares during the last quarter. S Bank Fund Management Ltd bought a new stake in Avantor during the first quarter valued at $80,000. Finally, Signaturefd LLC raised its holdings in shares of Avantor by 19.8% during the first quarter. Signaturefd LLC now owns 5,470 shares of the company’s stock worth $89,000 after purchasing an additional 904 shares during the period. 95.08% of the stock is currently owned by hedge funds and other institutional investors.
Avantor Stock Performance
AVTR stock opened at $13.48 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.98. Avantor, Inc. has a 1 year low of $10.82 and a 1 year high of $27.83. The stock’s fifty day moving average is $13.12 and its two-hundred day moving average is $14.19. The stock has a market capitalization of $9.19 billion, a price-to-earnings ratio of 13.61, a PEG ratio of 1.53 and a beta of 0.98.
Insider Transactions at Avantor
In other Avantor news, CAO Steven W. Eck sold 3,476 shares of the business’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the transaction, the chief accounting officer owned 55,068 shares in the company, valued at approximately $627,224.52. The trade was a 5.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.20% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on AVTR. Evercore ISI dropped their target price on shares of Avantor from $18.00 to $16.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Robert W. Baird dropped their target price on shares of Avantor from $18.00 to $15.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Jefferies Financial Group reissued a “hold” rating on shares of Avantor in a report on Friday, August 1st. JPMorgan Chase & Co. dropped their target price on shares of Avantor from $17.00 to $14.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Finally, Barclays reaffirmed an “overweight” rating and issued a $13.00 target price (down from $15.00) on shares of Avantor in a research report on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $15.50.
View Our Latest Stock Analysis on Avantor
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Recommended Stories
- Five stocks we like better than Avantor
- What Are Dividend Achievers? An Introduction
- Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Tencent Music Stock Outshines Spotify as China’s Music Giant
- What Are Trending Stocks? Trending Stocks Explained
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.